SUMMARY To investigate the possible role of gut and pancreatic hormones in the adaptive responses to gut resection, plasma concentrations of the circulating hormones were measured, in response to a test breakfast, in patients with either small or large intestinal resection and in healthy control subjects. In 18 patients with partial ileal resection a significant threefold rise was found in basal and postprandial levels of pancreatic polypeptide, a fourfold increase in motilin, and more than a twofold increase in gastrin and enteroglucagon levels compared with healthy controls. In contrast, nine patients with colonic resection had a threefold rise in levels of pancreatic polypeptide only. One or more of these peptides may have a role in stimulating the adaptive changes found after gut resection.
After small intestinal resection, there are two widely reported alterations in morphology and physiology. There is villous hyperplasia of the remaining small intestine 1-3 with an equivalent functional compensation. This presumably represents an adaptive process to compensate for the diminished absorptive surface area after resection.6 These adaptive responses are much more marked in the ileum after proximal small intestinal resection, but are also reported to occur in the jejunum after distal small bowel resection, albeit to a lesser extent7 8 and also in the colon.9 10 The mechanism of this process may well be humorally mediated '1-14 29 January 1982 In order to elucidate whether gut hormones might be implicated in any of these alterations, we have measured the circulating plasma concentrations of several gut hormones before and after a standard test breakfast in patients with resection of the small and large intestine and in age-and sex-matched healthy controls.
Methods

PATIENTS
Permission for these studies was obtained from the Ethical Committees at each of the participating centres and informed consent was given by all subjects tested.
SMALL INTESTINAL RESECTION
Eighteen patients (10 men, eight women) had previously undergone partial resection of the ileum. significantly raised fasting and postprandial plasma pancreatic polypeptide levels compared with control subjects. MOTILIN (Fig. 3) Patients with partial ileal resection had significantly raised basal levels, postprandial rises, and total integrated responses of plasma motilin. The group with colonic resection, however, had fasting plasma motilin levels which were similar to controls and an augmented postprandial response but this failed to reach statistical significance. ENTEROGLUCAGON (Fig. 4) Fasting plasma enteroglucagon levels, peak postprandial rises, and total integrated responses after the meal were all significantly greater than normal in the group with partial ileal resection. The group with colonic resection, however, had plasma enteroglucagon levels which were lower than control values but the difference did not reach statistical significance.
BLOOD GLUCOSE, INSULIN, GIP, PANCREATIC GLUCAGON, AND NEUROTENSIN There was no significant difference from normal in fasting or postprandial plasma levels or in total integrated responses of blood glucose, insulin, GIP, pancreatic glucagon or in neurotensin in either group of patients with gut resection.
There was no correlation between any of the peptides measured and the length of time since resection, the length of gut resected, or the frequency of bowel habit with the exception of pancreatic polypeptide, where there was a significant positive correlation of bowel frequency with individual total integrated responses in patients with small intestinal resection (r=0.59, p<O.O1).
Discussion
All the patients in this study had macroscopically normal proximal small intestines at operation apart from the two patients with massive resection of ileum and jejunum. In all but these two patients the plasma levels of glucose, insulin, pancreatic glucagon, and GIP were within normal limits after a standard meal. This confirms previous reports for glucose and insulin in man,34 for GIP in Rhesus monkeys35 and for insulin and pancreatic glucagon in dogs.36 Impaired glucose tolerance but with normal insulin release after oral glucose has been reported to occur short-term (four to five weeks) after distal resection.34 In another series, 13 patients were studied after massive small intestinal resection, seven of whom had jejunal resection as well as ileal. Fig. 4 Plasma enteroglucagon responses (mean ± SEM) to a test meal in 11 normal subjects and in 18 patients with small and in nine patients with large intestinal resection.
These patients had diminished insulin responses to oral glucose in both the short and long term.37 They attributed the differences in findings to differences in the patients studied and the extent of small intestinal resection. These patients, however, like ours, had normal fasting levels of pancreatic glucagon with normal responses of both insulin and glucagon to intravenous arginine. These findings are consistent with the belief that the enteric site of the entero-insular axis resides in the duodenum and jejunum. In contrast patients with intact but diseased small bowel due to coeliac disease or tropical malabsorption have an impaired enteroinsular response to the same stimulus.38 39 There is good evidence that a compensatory increase in cell number40 41 and absorptive function occurs in the ileum after resection of the jejunum and also, to a lesser extent, in the upper small intestine after ileal resection. Small intestinal adaptation has also been reported to occur after colectomy. 42 It has further been demonstrated that the increase in ileal mucosal mass is related to loss of colon itself and is not secondary to any increase in ileal nutrition or loss of fluid and electrolytes. 43 These adaptive responses have been attributed to the alteration of intraluminal content but there is also persuasive evidence that adaptation is also mediated by humoral mechanisms. Thus, small bowel, either transplanted within an animal after resection,44-46 or in animals parabiotically fed from resected animals,ii 47 48 undergoes adaptation in the absence of increased luminal nutrition. Enteroglucagon is a strong contestant for such a humoral factor. Thus circumstantial evidence, which includes data from the only reported secretory tumour of enteroglucagon49 and other work,50 suggests that this hormone is trophic to small intestinal mucosa including the jejunum. In rats, the intestinal response to starvation can be prevented by prior administration of glucagon-binding antibodies.51 It is likely that this effect is mediated by interaction of these antibodies with enteroglucagon rather than pancreatic glucagon, as exogenous glucagon has been shown to reduce villous height and cell migration in rat enteric mucosa.52 In an earlier, preliminary report in rats, raised enteroglucagon levels were found after both proximal and distal enteric resection. This was associated with hyperplasia of the enteroglucagon-containing cells and also with an increase in the enteroglucagon cell to enterocyte ratio.53 It is interesting that ileal resection is followed by an increase in plasma levels of enteroglucagon as the ileum is the richest site of enteroglucagon cells in the gut. 33 No correlation, however, was found between the length of ileum resected and circulating plasma enteroglucagon levels. Three patients could be classified as having massive small intestinal resection. One patient, with all but 70 cm of ileum resected for radiation-induced fibrosis had enteroglucagon levels which were slightly greater than the mean for the group. The second patient, who had had all his small intestine resected except for 4 cm of ileum and 10 cm of jejunum for traumatic infarction,24 had very low levels of enteroglucagon. The third patient, who had his entire ileum and all but 60 cm of jejunum resected for leiomyosarcoma had fasting enteroglucagon levels which were only just below the mean for the entire group. From this small number of patients it would seem that only if virtually the entire small intestine is resected do basal and postprandial enteroglucagon levels fail to rise. The remaining jejunum or ileum, along with the colon, must still be able to hypersecrete enteroglucagon despite resection of a large proportion of enteroglucagon-containing small bowel. In dogs with extensive distal small bowel resection no difference from control animals was found in fasting or stimulated enteroglucagon.54 There was no failure of release despite massive resection and the lack of rasied levels may be due to the extent of the resection, as in our second patient, or to species differences. Ileal mucosal hyperplasia has been described after colonic resection in the rat42 43 [55] [56] [57] and man.58 The colectomy patients had reduced basal levels but normal postprandial responses of enteroglucagon, although the reason for this is not apparent. No correlation was found between the length of colon resected and either basal or postprandial enteroglucagon responses. Thus, in our patients with colonic resection, if mucosal hyperplasia occurred, it was not expressed in an increase in plasma enteroglucagon levels, at least not during a test meal.
The great majority of patients studied had inflammatory bowel disease as the indication for gut resection. We found in unoperated patients with both Crohn's disease and ulcerative colitis only a slight rise in fasting enteroglucagon levels with only a very small postprandial rise. 59 We feel, therefore, that the striking rise in plasma enteroglucagon levels seen in patients with small intestinal resection reflects the effect of their surgery rather than the underlying pathological state.
The modest increases in plasma gastrin seen in these patients is consistent with previous reports.2i 36 The levels found are well within the physiological range, however, and these concentrations are known to be without effect on small bowel mucosal growth and are well below the levels induced by pharmacological gastrin and pentagastrin administration which have been found to induce hyperplasia in the duodenum but not in the remaining small bowel.60 Furthermore, massive endogenous hypergastrinaemia, as in achlohydria, does not produce any significant alteration in small intestinal structure or function.61 There is increasing evidence that gastrin is unlikely to be the mediator of intestinal adaption after intestinal resection. 62 63 Motilin, a peptide localised in the upper small intestine has recently been shown to exert a powerful effect on both small and large intestine.64
Plasma motilin has previously been found to be raised in several conditions accompanied by diarrhoea but, so far, it has not been clear whether this is a primary or secondary event.65 It is interesting, therefore, that motilin was raised regardless of whether patients complained of diarrhoea or not. Thus, it seems to be a direct response to ileal resection rather than to alteration of bowel habit. The rise of pancreatic polypeptide in both groups of patients is unexplained. The main physiological effects of this enigmatic hormone are to reduce gallbladder contraction66 and pancreatic enzyme secretion67 68 and to stimulate water absorption in the distal small intestine.69 In addition, low doses of pancreatic polypeptide reduced motility in both small and large intestine of the dog.70 An increase in intestinal absorptive capacity and alteration in motility could be seen as adaptive mechanisms in patients with ileal or colonic resection.
After gut resection there follows a compensatory adaption of the remaining intestine. There is good evidence that these changes are humorally mediated. We have found that patients with ileal resection have significantly raised plasma levels of gastrin, motilin, pancreatic polypeptide, and enteroglucagon. These peptides may possibly represent the circulating mediators of such adaptive responses. It would, therefore, be of great interest to follow up these findings with further studies correlating intestinal histology, mucosal cell kinetics, absorptive function, and circulating gut hormones in patients with intestinal resection. 
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